skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats

Original Research

(1331) Views  (992) Full article downloads

Authors: Ipek Özcan, Freimar Segura-Sánchez, Kawthar Bouchemal, et al

Published Date December 2010 Volume 2010:5 Pages 1103 - 1111
DOI: http://dx.doi.org/10.2147/IJN.S15493

Ipek Özcan1, Freimar Segura-Sánchez2,3, Kawthar Bouchemal2, Murat Sezak4, Özgen Özer1, Tamer Güneri1, Gilles Ponchel2
1Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Izmir, Turkey; 2Université Paris Sud-11, Faculty of Pharmacy, Physicochimie Pharmacotechnie Biopharmacie, Chatenay-Malabry, France; 3Universidad de Antioquia, Facultad de Química Farmacéutica, Departamento de Farmacia, Medellín, Colombia; 4Ege University, Faculty of Medicine, Department of Pathology, Izmir, Turkey

Abstract: Poly(γ-benzyl-L-glutamate) (PBLG) derivatives are synthetic polypeptides for preparing nanoparticles with well controlled surface properties. The aim of this paper was to investigate the biodistribution of pegylated PBLG in rats. For this purpose, nanoparticles were prepared by a nanoprecipitation method using mixtures of different PBLG derivates, including a pegylated derivate to avoid mononuclear phagocyte system uptake. The morphology, size distribution, and surface charge of the nanoparticles were investigated as a function of the amount of polymer employed for the preparation. Moderately polydispersed nanoparticles (polydispersity index less than 0.2) were obtained. Their size increased with polymer concentration. The zeta potential values were negative whatever the formulations. The availability of polyethylene glycol chains on the nanoparticles' surface was confirmed by measuring the decrease in bovine serum albumin adsorption. For in vivo distribution studies, pegylated and nonpegylated nanoparticles were prepared with polymer mixtures containing PBLG-fluorescein isothiocyanate and imaged by fluorescence microscopy to measure their accumulation in liver and spleen tissues of rats after intravenous administration. Injection of stealth formulations resulted in negligible fluorescence in liver and spleen compared with nonpegylated formulations, which suggests that these nanoparticles are promising candidates as a stealth-type long-circulating drug carrier system and could be useful for active targeting of drugs while reducing systemic side effects.

Keywords: PBLG, physicochemical characterization, biodistribution, nanoparticles, pegylation






Readers of this article also read:

Nanomedicine: promises and challenges for the future of public health
Types of neural guides and using nanotechnology for peripheral nerve reconstruction
Higher frequency of secretor phenotype in O blood group – its benefits in prevention and/or treatment of some diseases
Recent advances in PEG–PLA block copolymer nanoparticles
Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations
Size-dependent in vivo toxicity of PEG-coated gold nanoparticles
Solvent effects on structural and thermochemical properties of p53 tumor-suppressor gene: a molecular modeling approach in drug design
Adhesion of bio-functionalized ultrasound microbubbles to endothelial cells by targeting to vascular cell adhesion molecule-1 under shear flow
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines
Luminescent single-walled carbon nanotube-sensitized europium nanoprobes for cellular imaging